T1	PROC 44 58	Ensayo abierto
T2	PROC 64 110	evaluar la eficacia, seguridad y tolerabilidad
T3	CHEM 114 121	HZN-825
T4	LIVB 125 134	pacientes
#1	AnnotatorNotes T4	C0030705; Patients; Patient or Disabled Group
T5	DISO 139 174	esclerosis sistémica cutánea difusa
T6	PROC 195 236	Ensayo de extensión abierto multicéntrico
T7	PROC 242 288	evaluar la eficacia, seguridad y tolerabilidad
T8	CHEM 292 299	HZN-825
T9	LIVB 303 312	pacientes
#2	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 317 352	esclerosis sistémica cutánea difusa
T11	DISO 374 384	Enfermedad
#3	AnnotatorNotes T11	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T12	DISO 406 430	engrosamiento de la piel
#4	AnnotatorNotes T12	C0334008; Pachyderma; Pathologic Function
T13	DISO 432 440	fibrosis
#5	AnnotatorNotes T13	C0016059; Fibrosis; Pathologic Function
T15	ANAT 464 482	órganos del cuerpo
T16	DISO 507 542	Esclerosis sistémica cutánea difusa
T17	PROC 572 608	Consentimiento informado por escrito
T18	PROC 637 660	tratamiento doble ciego
T19	Date 662 671	semana 52
T20	LIVB 708 715	sujetos
#6	AnnotatorNotes T20	C0681850; Study Subject; Group
T21	PROC 720 762	suspendieron prematuramente el tratamiento
T22	CHEM 770 789	fármaco del estudio
#7	AnnotatorNotes T22	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T23	DISO 859 868	toxicidad
#8	AnnotatorNotes T23	C0600688; Toxic effect; Injury or Poisoning
T24	LIVB 904 916	investigador
#9	AnnotatorNotes T24	C0035173; Research Personnel; Professional or Occupational Group
T25	PROC 946 953	visitas
T26	PROC 1009 1021	evaluaciones
#10	AnnotatorNotes T26	C1261322; Evaluation procedure; Health Care Activity
T28	LIVB 1043 1049	Sujeto
#11	AnnotatorNotes T28	C0681850; Study Subject; Group
T32	PROC 1126 1138	evaluaciones
#15	AnnotatorNotes T32	C1261322; Evaluation procedure; Health Care Activity
T33	CHEM 1214 1238	fármaco en investigación
T34	PROC 1244 1250	tratar
T35	DISO 1261 1271	enfermedad
#16	AnnotatorNotes T35	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T36	PROC 1316 1327	diagnóstico
#17	AnnotatorNotes T36	C0011900; Diagnosis; Diagnostic Procedure
T37	DISO 1331 1348	neoplasia maligna
#18	AnnotatorNotes T37	C0006826; Malignant Neoplasms; Neoplastic Process | C1306459; Primary malignant neoplasm; Neoplastic Process
T38	Neg_cue 1403 1410	excepto
T39	DISO 1411 1460	carcinoma de células basales/escamosas de la piel
T40	Negated 1411 1460	carcinoma de células basales/escamosas de la piel
T41	DISO 1463 1499	cáncer de cuello de útero localizado
T42	Negated 1463 1499	cáncer de cuello de útero localizado
T43	PROC 1500 1507	tratado
T44	LIVB 1538 1560	Mujeres en edad fértil
T45	Age 1549 1560	edad fértil
T46	LIVB 1562 1565	MEF
T47	LIVB 1569 1576	varones
T48	Neg_cue 1581 1583	no
T49	PROC 1609 1632	métodos anticonceptivos
#19	AnnotatorNotes T49	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T50	Negated 1609 1632	métodos anticonceptivos
T51	Negated 1633 1652	altamente efectivos
T52	Duration 1686 1695	4 semanas
T54	CHEM 1727 1734	fármaco
#20	AnnotatorNotes T54	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T55	LIVB 1751 1758	varones
T56	Neg_cue 1765 1778	abstenerse de
T57	PROC 1779 1792	donar esperma
T58	Negated 1779 1792	donar esperma
T59	LIVB 1800 1807	mujeres
#21	AnnotatorNotes T59	C0043210; Woman; Population Group | C0242665; wife; Family Group
T60	PROC 1811 1823	donar óvulos
T61	Negated 1811 1823	donar óvulos
T62	LIVB 1884 1889	mujer
#22	AnnotatorNotes T62	C0043210; Woman; Population Group | C0242665; wife; Family Group
T63	Age 1898 1909	edad fértil
T64	PHYS 1932 1945	posmenopausia
#23	AnnotatorNotes T64	C0206159; Postmenopause; Organism Function
T65	Neg_cue 1948 1950	no
T66	PROC 1972 1997	esterilización quirúrgica
T67	Negated 1972 1997	esterilización quirúrgica
T68	PROC 2007 2031	salpingectomía bilateral
T69	PROC 2033 2055	ooforectomía bilateral
#24	AnnotatorNotes T69	C0278321; Bilateral oophorectomy; Therapeutic or Preventive Procedure
T70	PROC 2058 2071	histerectomía
#25	AnnotatorNotes T70	C0020699; Hysterectomy; Therapeutic or Preventive Procedure
T71	PHYS 2090 2111	estado posmenopáusico
#26	AnnotatorNotes T71	C0206159; Postmenopause; Organism Function
T73	Neg_cue 2130 2141	ausencia de
T74	PHYS 2142 2154	menstruación
#27	AnnotatorNotes T74	C0025344; Menstruation; Organism Function
T75	Negated 2142 2154	menstruación
T76	Duration 2163 2171	12 meses
T77	Neg_cue 2172 2175	sin
T79	CHEM 2230 2257	hormona foliculoestimulante
#28	AnnotatorNotes T79	C0733758; follicle stimulating hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T80	CHEM 2259 2262	FSH
#29	AnnotatorNotes T80	C0733758; follicle stimulating hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T83	PHYS 2328 2349	estado posmenopáusico
#30	AnnotatorNotes T83	C0206159; Postmenopause; Organism Function
T85	LIVB 2353 2360	mujeres
#31	AnnotatorNotes T85	C0043210; Woman; Population Group | C0242665; wife; Family Group
T86	Neg_cue 2365 2367	no
T87	CHEM 2373 2399	anticonceptivos hormonales
T88	Negated 2373 2399	anticonceptivos hormonales
T89	PROC 2402 2432	terapia de reposición hormonal
T90	Negated 2402 2432	terapia de reposición hormonal
T91	Neg_cue 2450 2461	ausencia de
T92	Duration 2462 2470	12 meses
T93	Negated 2462 2470	12 meses
T94	PHYS 2474 2483	amenorrea
T95	Negated 2474 2483	amenorrea
T96	PROC 2494 2512	medición de la FSH
#32	AnnotatorNotes T96	C0202022; Follicle stimulating hormone measurement; Laboratory Procedure
T97	LIVB 2534 2550	varones fértiles
T98	PROC 2557 2578	utilizar preservativo
T99	Duration 2612 2621	4 semanas
T102	LIVB 2676 2681	varón
T103	PHYS 2716 2724	pubertad
#34	AnnotatorNotes T103	C0034011; Puberty; Physiologic Function
T104	DISO 2757 2764	estéril
#35	AnnotatorNotes T104	C0021359; Infertility; Pathologic Function
T105	PROC 2769 2791	orquiectomía bilateral
#36	AnnotatorNotes T105	C0007347; Male Castration; Therapeutic or Preventive Procedure
T106	LIVB 2797 2842	Mujeres embarazadas o en período de lactancia
T107	DISO 2874 2884	enfermedad
#37	AnnotatorNotes T107	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T108	LIVB 2902 2908	sujeto
#38	AnnotatorNotes T108	C0681850; Study Subject; Group
T109	LIVB 3015 3027	investigador
#39	AnnotatorNotes T109	C0035173; Research Personnel; Professional or Occupational Group
T110	Spec_cue 3029 3035	podría
T111	LIVB 3045 3051	sujeto
#40	AnnotatorNotes T111	C0681850; Study Subject; Group
T112	Speculated 3058 3064	riesgo
T113	Speculated 3065 3076	inaceptable
T114	LIVB 3085 3092	sujetos
#41	AnnotatorNotes T114	C0681850; Study Subject; Group
T115	Neg_cue 3093 3095	no
T116	Negated 3102 3111	elegibles
T117	LIVB 3131 3143	investigador
#42	AnnotatorNotes T117	C0035173; Research Personnel; Professional or Occupational Group
T118	Spec_cue 3148 3161	poco probable
T119	Speculated 3166 3201	cumplan con el protocolo del ensayo
T120	PROC 3181 3201	protocolo del ensayo
#43	AnnotatorNotes T120	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T121	DISO 3215 3225	enfermedad
#44	AnnotatorNotes T121	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T122	DISO 3228 3249	afección concomitante
T123	Spec_cue 3254 3259	pueda
T124	Speculated 3260 3270	interferir
T125	Date 12 16	2021
T14	PROC 679 685	ensayo
T126	PROC 796 802	ensayo
T127	Neg_cue 832 838	ajenas
T128	Negated 844 853	seguridad
T129	Negated 859 868	toxicidad
T130	PROC 970 976	ensayo
T131	PROC 1155 1161	ensayo
T29	PROC 1085 1119	protocolo de tratamiento prescrito
T30	PROC 1298 1304	ensayo
T31	PROC 1378 1384	ensayo
T132	PROC 1669 1675	ensayo
T53	Neg_cue 1913 1915	no
T133	Negated 1932 1945	posmenopausia
T135	Negated 2033 2055	ooforectomía bilateral
T136	Negated 2058 2071	histerectomía
T72	CHEM 2653 2671	fármaco del ensayo
T100	PHYS 2695 2701	fértil
T101	Age 2716 2724	pubertad
T134	Negated 2007 2031	salpingectomía bilateral
T81	PHYS 2281 2295	posmenopáusico
T138	PROC 2595 2601	ensayo
T142	PROC 3293 3299	ensayo
T141	PROC 2971 2977	ensayo
T144	Date 1028 1037	semana 52
T27	Negated 2180 2204	causa médica alternativa
T78	Spec_cue 2297 2302	puede
T82	Speculated 2315 2349	confirmar un estado posmenopáusico
T143	Speculated 3278 3299	desarrollo del ensayo
